Cancer prevention · September 26, 2026

Lung Cancer Screening: When a Scan Helps and When It Does Not

Annual low-dose CT screening can reduce lung-cancer mortality for people at high risk. It is not a general-purpose scan, and the eligibility details determine whether its expected benefit is likely to exceed its harms.

low-dose CT · pack-years · smoking cessation · shared decision-making

The screening decision begins with smoking exposure, age, and time since quitting. A low-dose CT is different from a diagnostic scan for symptoms: screening is for people without symptoms who meet defined risk criteria.

The current USPSTF recommendation is annual low-dose CT for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years. It should stop after 15 years without smoking or when health limits the ability or willingness to undergo curative surgery.

Calculate smoking exposure accurately

A pack-year is one pack of cigarettes per day for one year. One pack a day for 20 years equals 20 pack-years; two packs a day for 10 years also equals 20. This estimate should be reconstructed with a clinician, especially when smoking intensity changed over time.

Decision diagram showing low-dose CT eligibility by age, pack-year smoking history, and years since quitting
Eligibility depends on age, cumulative smoking exposure, and the interval since quitting.

What the scan can and cannot do

Low-dose CT can find lung cancer earlier in high-risk groups. It does not prevent cancer and it does not replace stopping smoking. The USPSTF found moderate certainty of a moderate net benefit only when screening is limited to people at high risk and follow-up resembles the care pathways used in trials.

Chest x-rays, sputum testing, and biomarker tests are not substitutes for recommended low-dose CT screening. A new cough, coughing blood, unexplained weight loss, or other concerning symptoms should prompt clinical assessment rather than a screening pathway.

Clinical conversation checklist covering smoking history, quitting date, symptoms, follow-up, and smoking cessation support
A sound screening referral includes a plan for follow-up and support to stop smoking.

Screening has real tradeoffs

CT screening can identify nodules that prove not to be cancer. Follow-up imaging, invasive testing, incidental findings, anxiety, radiation exposure, and overdiagnosis are potential harms. The appropriate question is not whether a scan is harmless; it is whether its expected benefit is favorable for a particular risk profile.

Question for the appointmentWhy it changes the decision
What is the smoking history in pack-years?It is part of the eligibility threshold.
When did smoking stop?The USPSTF screening recommendation ends after 15 smoke-free years.
Are there symptoms now?Symptoms may require diagnostic evaluation rather than screening.
Would treatment be possible if cancer were found?Screening is not recommended when health substantially limits curative treatment.

Use the scan as one prevention decision

Screening programs should pair referral with smoking-cessation treatment for people who currently smoke. The sleep-apnea guide shows why targeted testing must match the condition and risk profile; the prevention planning framework explains how to prioritize evidence-backed prevention without treating screening as a longevity score.

Sources

This article is educational and does not provide medical advice, diagnosis, or an individual screening recommendation.

LifeMeter